Oral lac-phe pill aims to mimic exercise, preserving muscle during weight loss in early trials
Enveda reports Phase 1 results for an oral drug candidate that mimics the exercise-induced lactate-phenylalanine pathway (lac-phe) to curb appetite and preserve lean muscle, with the goal of maintaining weight loss without the GI side effects seen with GLP-1 drugs.
